We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CNTG market cap is 8.97M. The company's latest EPS is EUR -1.2876 and P/E is -0.25.
| Quarter End | Dec 2019 | Sep 2020 | Dec 2020 | Sep 2021 | Dec 2021 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 15.22M | 36.31M | 69.54M | 30.2M | 41.54M |
| Operating Income | -4.32M | -1.9M | 3.46M | -20.94M | -12.01M |
| Net Income | -5.02M | -5.64M | 2.75M | -21.64M | -11.69M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 48.78M | 127.67M | 188.57M | 66.93M | 48.54M |
| Operating Income | -18.14M | -16.67M | -44.53M | -29.16M | -28.77M |
| Net Income | -20.86M | -21.99M | -46.25M | -31.84M | -35.53M |
| Quarter End | Dec 2019 | Sep 2020 | Dec 2020 | Sep 2021 | Dec 2021 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 117.51M | 121.74M | 149.92M | 96.19M | 91.14M |
| Total Liabilities | 58.59M | 62.38M | 84.99M | 58.81M | 63.88M |
| Total Equity | 58.92M | 59.36M | 64.93M | 37.38M | 27.26M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 117.51M | 149.92M | 91.14M | 92.81M | 77.16M |
| Total Liabilities | 58.59M | 84.99M | 63.88M | 85.4M | 102.44M |
| Total Equity | 58.92M | 64.93M | 27.26M | 7.41M | -25.28M |
| Quarter End | Dec 2019 | Sep 2020 | Dec 2020 | Sep 2021 | Dec 2021 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -7.78M | -19.67M | 8.46M | -14.98M | -21.74M |
| Investing | 14.18M | -11.03M | -16.15M | -5.4M | -5.36M |
| Financing | 25.47M | 18.35M | 14.84M | -2.05M | -3.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -7.78M | 8.46M | -21.74M | -26.49M | -31.75M |
| Investing | 14.18M | -16.15M | -5.36M | -733k | 2.28M |
| Financing | 25.47M | 14.84M | -3.2M | 46.32M | 13.04M |
| Market Cap | 8.97M |
| Price to Earnings Ratio | -0.25 |
| Price to Sales Ratio | 0.18 |
| Price to Cash Ratio | 0.46 |
| Price to Book Ratio | -0.35 |
| Dividend Yield | - |
| Shares Outstanding | 27.6M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (3.47%) |
| Company Name | Centogene NV |
| Address |
am strande 7 rostock 18055 |
| Website | https://www.centogene.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
